🟢 Pacific Biosciences is trading 5% up; no clear catalyst identified

Pacific Biosciences is trading 5.27% up at $2.50 on October 1, extending a multi-session rally with no clearly established catalyst for the latest increase. - On September 30, shares gained 29.51% to $2.37. - September 30 coverage tied that surge to EpiSign’s launch of METRIC 5-base software, which supports analysis using PacBio HiFi sequencing. - Broad indexes were mixed and up less than 0.5%; the evidence does not establish a direct cause for the October 1 rise.